Nikhil Lalwani, President and Chief Executive Officer

Mr. Lalwani is ANI’s President and Chief Executive Officer and a member of ANI’s Board. Prior to joining ANI in September 2020, Mr. Lalwani worked at Cipla Ltd (NSE: CIPLA), a global pharmaceutical company, from May 2012 to August 2020 where he held positions of increasing responsibility, including CEO of Cipla USA, CEO of InvaGen, Head of US Strategy, M&A & Integration, and Head of Cipla’s Global Respiratory business. In these roles, Mr. Lalwani developed and executed multi-year strategic growth plans for key products and facilitated successful acquisitions as Cipla entered the specialty pharmaceutical space. Prior to Cipla, Mr. Lalwani was an Associate Partner with McKinsey & Company serving pharmaceutical and healthcare companies across the world, and an engineer with Medtronic. Mr. Lalwani holds a B.S. in Electrical Engineering from Georgia Institute of Technology and an M.B.A. from the Wharton School at the University of Pennsylvania.

Stephen P. Carey, Senior Vice President and Chief Financial Officer

Mr. Carey has been the Company’s Vice President, Finance and Chief Financial Officer since May 2016, and a Sr. Vice President since December 2020. From June 2007 to October 2015, Mr. Carey held various executive financial positions at Par Pharmaceutical Companies, Inc., including Senior Vice President, Controller and Principal Accounting Officer. Prior to that, Mr. Carey held various financial and accounting positions at Schering-Plough Corporation. Mr. Carey has over 25 years of experience as a financial executive, 20 of which are in the pharmaceutical industry. Mr. Carey began his career at PricewaterhouseCoopers. Mr. Carey graduated from Montclair State University with a B.S. degree in Accounting.

James G. Marken, Sr. Vice President, Operations and Product Development

Mr. Marken provides leadership for the production, engineering and logistics functions for the company's multi-site prescription drug, and potent compound facilities in Baudette, Minnesota. Mr. Marken brings over 20 years of pharmaceutical industry experience to his position. Prior to joining ANI Pharmaceuticals in 2007 as General Manager of the Minnesota facilities, he worked for Solvay Pharmaceuticals in various departments including Quality Control, Validation and Manufacturing. Mr. Marken holds a B.S. degree in Chemistry from Bemidji State University.

Robert Schrepfer, Sr. Vice President, Business Development and Specialty Sales

Mr. Schrepfer is responsible for identifying and advancing ANI's product pipeline and contract manufacturing opportunities. Prior to joining ANI, Mr. Schrepfer served as Managing Director and Assistant Portfolio Manager at Healthcare Value Capital, a healthcare investment firm, since 2005. Previously, Mr. Schrepfer was Vice President, Equity Research covering the Major and Specialty Pharmaceuticals sector at Bear Stearns & Cos, Inc. Mr. Schrepfer is a Member of the Health Sector Advisory Council at Duke University where he earned his MBA in Finance and Health Sector Management.